Profile | GDS2987 / GI_17402876-A |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 1347.8 | 95 |
GSM215298 | PASMC_vehicle_rep2 | 1395.1 | 95 |
GSM215310 | PASMC_vehicle_rep3 | 1286 | 95 |
GSM215311 | PASMC_atorvastatin_rep1 | 1347.2 | 95 |
GSM215312 | PASMC_atorvastatin_rep2 | 1488.8 | 96 |
GSM215313 | PASMC_atorvastatin_rep3 | 1290.2 | 95 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 1628.6 | 96 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 1436.8 | 95 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 1291.6 | 95 |
GSM215327 | PASMC_SLx2119_rep1 | 1025.6 | 94 |
GSM215328 | PASMC_SLx2119_rep2 | 999.7 | 94 |
GSM215329 | PASMC_SLx2119_rep3 | 1136.8 | 94 |
GSM215330 | Fibroblasts_vehicle_rep1 | 165.5 | 80 |
GSM215331 | Fibroblasts_vehicle_rep2 | 174.7 | 80 |
GSM215332 | Fibroblasts_vehicle_rep3 | 170 | 80 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 130.1 | 78 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 174.3 | 80 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 170.3 | 80 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 160 | 80 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 178 | 81 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 150.1 | 79 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 167.6 | 80 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 247.7 | 84 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 227.3 | 83 |